"Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial." Eli Lilly and Company , 11 Dec
It does not accept insurance for any of its GLP-1 treatments
People with type 1 diabetes should be aware of symptoms of DKA like nausea, abdominal pain, fruity odor on breath and have access to home ketone tests, Wright added
Ma MZ, Chen G, Wang P, Lu WH, Zhu CF, Song M, et al
Ricks emphasized the company's commitment to lowering patients' out-of-pocket costs with a price target aiming between $100-300